Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANOA: Clopidogrel for Migraine Prevention after ASD Closure
NCT00799045Phase 4Completed
- Sponsor
- Université Laval
- Start
- Oct 2008
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in migraine, sponsored by Université Laval. Started Oct 2008; status: completed.
02
Drugs
clopidogrel
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00799045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799045.